WallStreetZenWallStreetZen

NYSE: HAE
Haemonetics Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for HAE

Based on 1 analyst offering 12 month price targets for Haemonetics Corp.
Min Forecast
$105.00+19.78%
Avg Forecast
$105.00+19.78%
Max Forecast
$105.00+19.78%

Should I buy or sell HAE stock?

Based on 1 analyst offering ratings for Haemonetics Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HAE stock forecasts and price targets.

HAE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12

1 of 1

Forecast return on equity

Is HAE forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is HAE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

HAE revenue forecast

What is HAE's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.3B+6.19%
Avg 2 year Forecast
$1.4B+12.8%
Avg 3 year Forecast
$1.6B+29.6%
HAE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HAE earnings growth forecast

How is HAE forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
25.91%
Industry
23.81%
Market
21.46%
HAE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HAE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HAE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HAE revenue growth forecast

How is HAE forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
7.94%
Industry
8.57%
Market
9.92%
HAE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HAE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HAE vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
HAE$87.66$105.00+19.78%Buy
MMSI$73.38$93.00+26.74%Buy
BLCO$14.76$18.00+21.95%Buy
NVST$20.02$28.38+41.73%Buy
AZTA$51.50$69.60+35.15%Buy
View Top Medical Stocks

Haemonetics Stock Forecast FAQ

Is Haemonetics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: HAE) stock is to Buy HAE stock.

Out of 1 analyst, 0 (0%) are recommending HAE as a Strong Buy, 1 (100%) are recommending HAE as a Buy, 0 (0%) are recommending HAE as a Hold, 0 (0%) are recommending HAE as a Sell, and 0 (0%) are recommending HAE as a Strong Sell.

If you're new to stock investing, here's how to buy Haemonetics stock.

What is HAE's revenue growth forecast for 2025-2027?

(NYSE: HAE) Haemonetics's forecast annual revenue growth rate of 7.94% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Haemonetics's revenue in 2024 is $1,270,181,000.On average, 3 Wall Street analysts forecast HAE's revenue for 2025 to be $68,503,514,135, with the lowest HAE revenue forecast at $66,882,776,783, and the highest HAE revenue forecast at $71,536,816,545. On average, 3 Wall Street analysts forecast HAE's revenue for 2026 to be $72,764,621,710, with the lowest HAE revenue forecast at $70,222,979,698, and the highest HAE revenue forecast at $76,092,331,240.

In 2027, HAE is forecast to generate $83,600,042,916 in revenue, with the lowest revenue forecast at $83,600,042,916 and the highest revenue forecast at $83,600,042,916.

What is HAE's forecast return on assets (ROA) for 2025-2027?

(NYSE: HAE) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of N/A.

What is HAE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HAE price target, the average HAE price target is $105.00, with the highest HAE stock price forecast at $105.00 and the lowest HAE stock price forecast at $105.00.

The Wall Street analyst predicted that Haemonetics's share price could reach $105.00 by Apr 12, 2025. The average Haemonetics stock price prediction forecasts a potential upside of 19.78% from the current HAE share price of $87.66.

What is HAE's forecast return on equity (ROE) for 2025-2027?

(NYSE: HAE) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.